GRAIL
Healthcare AI
Cancer detection / multi-cancer early detection diagnostics
Public
GRAIL is a healthcare company focused on early cancer detection, best known for developing the Galleri multi-cancer early detection blood test. The company uses next-generation sequencing, population-scale clinical studies, machine learning, software, and automation to detect multiple cancer types earlier, and it is positioned in the AI healthcare / diagnostics space rather than as a general AI software company.
Company Details
- Website
- grail.com
- Headquarters
- Menlo Park, California, United States
- Founded
- 2016
- Funding
- $2.1B
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring